While AOD 9604 targets your metabolism directly, GLP-1s affect appetite and insulin signaling, with no overlap between the two
Clients with known deficiency, gastrointestinal absorption issues, or strict plant-based diets are candidates for ongoing injection series
However, ideal storage temperatures range between 59-77f / 15-25c
This metabolic safety profile makes AOD-9604 potentially suitable for individuals with metabolic syndrome or diabetes risk factors who might not tolerate traditional growth hormone therapy, though medical supervision remains appropriate
The optimal dosing, administration route, and cycling protocol for humans remain uncertain
For the best possible outcome it is advised that you initially have loading doses - this would be carried out as 1 injection every 3-4 weeks